A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Monthly Subcutaneous Administration of Tonlamarsen in Participants With Uncontrolled Hypertension (KARDINAL)
Latest Information Update: 03 Apr 2026
At a glance
- Drugs Tonlamarsen (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Kardigan
Most Recent Events
- 31 Mar 2026 Status changed from active, no longer recruiting to completed.
- 28 Mar 2026 According to a Kardigan media release, Data from this trial were presented at the American College of Cardiologys Annual Scientific Session & Expo (ACC.26) and simultaneously published in The Journal of the American College of Cardiology (JACC).
- 28 Mar 2026 Results presented in the Kardigan media release.